Last Updated 24 September 2021.
10 Vaccines Approved for Use in Philippines
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 100 countries
33 trials in 16 countries
Approval Source: bloomberg.com
-
Moderna
mRNA-1273- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 72 countries
28 trials in 2 countries
Approval Source: reuters.com
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 15 countries
4 trials in 2 countries
Approval Source: reuters.com
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 71 countries
21 trials in 2 countries
Approval Source: reuters.com
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 66 countries
10 trials in 16 countries
Approval Source: reuters.com
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 122 countries
40 trials in 2 countries
Approval Source: bloomberg.com
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 9 countries
7 trials in 1 country
Approval Source: reuters.com
-
Sinopharm (Beijing)
BBIBP-CorV (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 64 countries
11 trials in 4 countries
Approval Source: bloomberg.com
-
Sinopharm (Wuhan)
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
8 trials in 6 countries
Approval Source: fda.gov.ph
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
19 trials in 2 countries
Approval Source: reuters.com
2 Vaccines in Clinical Trials in Philippines
-
West China Hospital
Recombinant (Sf9 cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 4 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 66 countries
10 trials in 16 countries